Correlation between the presence of breast tumor cells in bone marrow at the time of surgery and disease progressionCOLNAGHI, M. I.Developments in oncology. 1989, Vol 58, pp 187-196, issn 0167-4927Conference Paper

Natural antibodies to oncogenic viruses, tumour cells and other antigensBOICCHI, M; COLNAGHI, M. I.Clinics in immunology and allergy. 1983, Vol 3, Num 3, pp 365-387, issn 0260-4639Article

Type 4 chain H expression by bile ductules and hepatocytes in cirrhosisOKADA, Y; COLNAGHI, M. I; TSUJI, T et al.Journal of pathology. 1989, Vol 157, Num 4, pp 329-338, issn 0022-3417Article

Immunoconjugates : lessons from animal modelsCANEVARI, S; COLOMBATTI, M; COLNAGHI, M. I et al.Annals of oncology. 1994, Vol 5, Num 8, pp 698-701, issn 0923-7534Article

Monoclonal antibodies in immunodiagnosis and immunotherapy of human cancerCOLNAGHI, M. I; CANEVARI, S; MENARD, S et al.European journal of surgical oncology. 1988, Vol 14, Num 1, pp 1-7, issn 0748-7983Article

Anti-drug monoclonal antibodies antagonize toxic effect more than anti-tumor activity of doxorubicinBALSARI, A; MENARD, S; COLNAGHI, M. I et al.International journal of cancer. 1991, Vol 47, Num 6, pp 889-892, issn 0020-7136, 4 p.Article

Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in miceMORELLI, D; MENARD, S; COLNAGHI, M. I et al.Cancer research (Baltimore). 1996, Vol 56, Num 9, pp 2082-2085, issn 0008-5472Article

Internalization of a monoclonal antibody against human breast cancer by immunoelectron microscopyDELLA TORRE, G; CANEVARI, S; ORLANDI, R et al.British journal of cancer. 1987, Vol 55, Num 4, pp 357-359, issn 0007-0920Article

Heterogeneity of the natural humoral anti-tumor immune response in mice as shown by monoclonal antibodiesCOLNAGHI, M. I; MENARD, S; TAGLIABUE, E et al.The Journal of immunology (1950). 1982, Vol 128, Num 6, pp 2757-2762, issn 0022-1767Article

The 67 kDa laminin receptor as a prognostic factor in human cancerMENARD, S; TAGLIABUE, E; COLNAGHI, M. I et al.Breast cancer research and treatment. 1998, Vol 52, Num 1-3, pp 137-145, issn 0167-6806Article

Characterization of a mouse-human chimeric antibody to a cancer-associated antigenORLANDI, R; TOMASSETTI, A; CANEVARI, S et al.International journal of cancer. 1992, Vol 52, Num 4, pp 588-593, issn 0020-7136Article

Generation of monoclonal antibodies for In vitro approachesCOLNAGHI, M. I.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 1, pp 15-18, issn 0883-2897Conference Paper

Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patientsPUPA, S. M; MENARD, S; ANDREOLA, S et al.Cancer research (Baltimore). 1993, Vol 53, Num 24, pp 5864-5866, issn 0008-5472Article

Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell linePUPA, S. M; HOWARD, C. M; INVERNIZZI, A. M et al.Oncogene (Basingstoke). 1999, Vol 18, Num 3, pp 651-656, issn 0950-9232Article

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiographyLI, P. Y; DEL VECCHIO, S; SALVATORE, M et al.The Journal of nuclear medicine (1978). 1996, Vol 37, Num 4, pp 665-672, issn 0161-5505Article

Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomasPUPA, S. M; BUFALINO, R; INVERNIZZI, A. M et al.Journal of clinical oncology. 1996, Vol 14, Num 1, pp 85-94, issn 0732-183XArticle

Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killingCONEY, L. R; MEZZANZANICA, D; SANBORN, D et al.Cancer research (Baltimore). 1994, Vol 54, Num 9, pp 2448-2455, issn 0008-5472Article

Prognostic significance of the CaMBr1 antigen on breast carcinoma : relevance of the type of recognised glycoconjugatePERRONE, F; MENARD, S; CANEVARI, S et al.European journal of cancer. Part A. 1993, Vol 29, Num 15, pp 2113-2117Article

Study of the expression and function of the tumour-associated antigen CaMBr1 in small cell lung carcinomasMARTIGNONE, S; MENARD, S; BEDINI, A et al.European journal of cancer. Part A. 1993, Vol 29, Num 14, pp 2020-2025Article

Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicityCANEVARI, S; MEZZANZANICA, D; MENARD, S et al.International journal of cancer. Supplement. 1992, Num 7, pp 42-44, issn 0898-6924Conference Paper

Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies : role of different triggering moleculesFERRINI, S; CAMBIAGGI, A; CANTONI, C et al.International journal of cancer. Supplement. 1992, Num 7, pp 15-18, issn 0898-6924Conference Paper

Selection of monoclonal antibodies which induce internalization and phosphorylation of p185^HER2 and growth inhibition of cells with HER2/NEU gene amplificationTAGLIABUE, E; CENTIS, F; CAMPIGLIO, M et al.International journal of cancer. 1991, Vol 47, Num 6, pp 933-937, issn 0020-7136, 5 p.Article

Re-targeting of human lymphocytes expressing the T-cell receptor gamma/delta to ovarian carcinoma cells by the use of bispecific monoclonal antibodiesFERRINI, S; PRIGIONE, I; MAMMOLITI, S et al.International journal of cancer. 1989, Vol 44, Num 2, pp 245-250, issn 0020-7136, 6 p.Article

Human renal antigen defined by a murine monoclonal antibodyTAGLIABUE, E; CANEVARI, S; MENARD, S et al.Journal of the National Cancer Institute. 1984, Vol 73, Num 2, pp 363-369, issn 0027-8874Article

Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterationsFORMANTICI, C; ORLANDI, R; RONCHINI, C et al.Journal of pathology. 1999, Vol 187, Num 4, pp 424-427, issn 0022-3417Article